Literature DB >> 10469377

Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis.

M Boaz1, Z Matas, A Biro, Z Katzir, M Green, M Fainaru, S Smetana.   

Abstract

BACKGROUND: Oxidative stress has been proposed as a mechanism by which the accelerated rate of cardiovascular disease (CVD) observed in maintenance hemodialysis (HD) patients may be explained. This study examined the effects of HD and CVD on serum malondialdehyde (MDA) levels as a marker of oxidative stress in HD patients with and without prevalent CVD. Serum MDA levels and CVD prevalence in HD were modeled.
METHODS: Serum MDA was determined using spectrophotometry in HD patients (N = 76, 53 men and 23 women, mean age 63.8 years) immediately prior to and at the conclusion of one midweek HD treatment. Traditional CVD risk factors, including serum lipids, lipoproteins, apolipoproteins, and fibrinogen, were also measured, as were serum chemistry and dialysis adequacy.
RESULTS: Mean serum MDA levels were significantly elevated in HD patients with prevalent CVD compared with those without, whereas serum lipoprotein and plasma fibrinogen levels did not differ between the two groups. Patients in the highest compared with the lowest tertile of postdialysis MDA were nearly four times as likely to have prevalent CVD, and serum MDA was the single strongest predictor of prevalent CVD in this patient population.
CONCLUSIONS: These findings indicate the presence of oxidative stress in HD patients, and are consistent with the theory of oxidative stress as a factor in accelerated CVD in this population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469377     DOI: 10.1046/j.1523-1755.1999.00613.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

1.  Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients.

Authors:  Davide Soldini; Hugo Zwahlen; Luca Gabutti; Antonio Marzo; Claudio Marone
Journal:  Eur J Clin Pharmacol       Date:  2005-01-19       Impact factor: 2.953

2.  Effects of ageing on metabolite and oxidant concentrations in different regions of rat kidney under normal and stress conditions.

Authors:  Noor Riyadh Thiab; Nicola King; Graham L Jones
Journal:  Mol Cell Biochem       Date:  2015-06-23       Impact factor: 3.396

3.  A novel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits.

Authors:  Xiang Li; Dalin He; Linlin Zhang; Xinfa Cheng; Binwu Sheng; Yong Luo
Journal:  Urol Res       Date:  2006-06-17

4.  The protective effects of the traditional Chinese herbs against renal damage induced by extracorporeal shock wave lithotripsy: a clinical study.

Authors:  Binwu Sheng; Dalin He; Jun Zhao; Xingfa Chen; Xunyi Nan
Journal:  Urol Res       Date:  2010-07-06

5.  Effect of medial calcification on vascular function in uremia.

Authors:  Roy L Sutliff; Erik R Walp; Alexander M El-Ali; Stacey Elkhatib; Koba A Lomashvili; W Charles O'Neill
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-06

6.  Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice.

Authors:  Xinmei Zhu; Hang Pong Ng; Yen-Chun Lai; Jodi K Craigo; Pruthvi S Nagilla; Pooja Raghani; Shanmugam Nagarajan
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

7.  Treatment of renal calculi by lithotripsy: minimizing short-term shock wave induced renal damage by using antioxidants.

Authors:  Khaleel A Al-Awadi; Elijah O Kehinde; Issa Loutfi; Olusegun A Mojiminiyi; Adel Al-Hunayan; Hamdy Abdul-Halim; Ahmed Al-Sarraf; Anjum Memon; Mathew P Abraham
Journal:  Urol Res       Date:  2007-12-07

Review 8.  Oxidative stress in chronic kidney disease.

Authors:  Kristien Daenen; Asmin Andries; Djalila Mekahli; Ann Van Schepdael; François Jouret; Bert Bammens
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

9.  Using Anti-Malondialdehyde Modified Peptide Autoantibodies to Import Machine Learning for Predicting Coronary Artery Stenosis in Taiwanese Patients with Coronary Artery Disease.

Authors:  Yu-Cheng Hsu; I-Jung Tsai; Hung Hsu; Po-Wen Hsu; Ming-Hui Cheng; Ying-Li Huang; Jin-Hua Chen; Meng-Huan Lei; Ching-Yu Ling
Journal:  Diagnostics (Basel)       Date:  2021-05-26

10.  Lipid and protein oxidation in female patients with chronic fatigue syndrome.

Authors:  Slavica Tomic; Snezana Brkic; Daniela Maric; Aleksandra Novakov Mikic
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.